The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aldeyra Therapeutics, Inc(NASDAQ:ALDX) 
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, an ophthalmic solution, which is in Phase III clinical trial for the treatment of dry eye diseases and alle...
Website: http://www.aldeyra.com
Founded: 2004
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
Aldeyra Therapeutics Days Payable Outstanding ttm (DPO)
Aldeyra Therapeutics Op Cashflow Per Share ttm
Aldeyra Therapeutics Free Cashflow Per Share ttm
Aldeyra Therapeutics Cash Per Share ttm
Aldeyra Therapeutics P/S ratio ttm
Aldeyra Therapeutics (GAAP) P/E ratio ttm
Aldeyra Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.